FB
Fortress Biotech, Inc.
FBIO · NASDAQ
$2.46 -0.81% (-$0.02)
1M -15.46%
Market Cap $81.7M
P/E Ratio 0.73x
Div. Yield -
ROE 103.52%
Piotroski F-Score Moderate
6/9Valuation
100 /100
Cheap P/E 0.73x
P/S 1.19x
P/B 0.50x
Growth
13 /100
Declining Rev. growth 5.83%
Book val. growth 6.13%
EPS growth N/A
Profitability
70 /100
Strong Gross margin 62.53%
Net margin 163.32%
Op. margin 42.86%
Quality
48 /100
Average ROIC 10.85%
ROE 103.52%
ROA 35.31%
Debt
98 /100
Low Debt/Equity 0.39x
Current ratio 3.96x
Int. coverage 17.26x
Stability
53 /100
Moderate Beta 1.19x
Rev. volatility 24.49%
EPS volatility 27.87%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o FBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lindsay A. Rosenwald
Employees
78
Headquarters
Bay Harbor Islands
Prihajajoči dogodki
16 NOV.
Earnings
Upcoming earnings report